跳至主要内容
临床试验/NL-OMON53247
NL-OMON53247尚未招募不适用

Vision-MR Ablation Catheter 2.0 for Treatment of Ventricular Tachycardia - VISABL-VT study

Imricor Medical Systems, Inc0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion Criteria
  • Documented (ECG/EGM) spontaneous episode of sustained ventricular
  • tachycardia within 6 months
  • Diagnosis of ischemic cardiomyopathy
  • AAD therapy refractory, contraindicated, not tolerated, or not desired
  • 18 years or older

排除标准

  • Exclusion Criteria • Implanted with non-MR compatible medical devices or
  • contraindicated for an MRI • Presence of intracardiac thrombus (verified via
  • CT/MRI/TEE/TTE within 48 hours of procedure - or at start of procedure) •
  • Thrombocytopenia or coagulopathy • Mechanical mitral and/or aortic valve
  • precluding access to the left ventricle • Severe aortic stenosis • Myocardial
  • infarction requiring stent implantation within 90 days of procedure • Previous
  • cardiac surgery within 60 days of procedures • Class IV Heart Failure • EF <
  • 25% • Patients with a glomerular filtration rate (GFR) < 30 • Women who are
  • pregnant • Life expectancy < 12 months • Enrollment in another study without
  • Imricor approval

研究者

相似试验